These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7192584

  • 1. [Use of heterologous antireceptor antibodies for specific reversal of acute homologous disease in mice].
    Nesterenko VG, Gruner Sh, Rubakova EI, Babadzhanov AS.
    Biull Eksp Biol Med; 1980 Nov; 90(11):588-90. PubMed ID: 7192584
    [Abstract] [Full Text] [Related]

  • 2. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC, Tibbe GJ, Noort WA, Bril-Bazuin C, Benner R, Savelkoul HF.
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [Abstract] [Full Text] [Related]

  • 3. Anti-lymphocytic antibodies and marrow transplantation. 3. Effect of heterologous anti-brain antibodies on acute secondary disease in mice.
    Rodt H, Thierfelder S, Eulitz M.
    Eur J Immunol; 1974 Jan; 4(1):15-9. PubMed ID: 4152781
    [No Abstract] [Full Text] [Related]

  • 4. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC, Friedman TM, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
    [Abstract] [Full Text] [Related]

  • 5. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T, Eto M, Lin T, Nishimura Y, Kong YY, Nomoto K, Nomoto K.
    J Immunol; 1994 Nov 01; 153(9):4311-20. PubMed ID: 7930630
    [Abstract] [Full Text] [Related]

  • 6. Blocking activity of the serum from semiallogeneic chimaeras produced by means of cyclophosphamide.
    Nagurskaya EV, Chernyakhovskaya IJ, Fontalin LN.
    Folia Biol (Praha); 1984 Nov 01; 30(4):209-20. PubMed ID: 6383881
    [Abstract] [Full Text] [Related]

  • 7. [Formation of antibodies against the antigen-recognizing receptors of T-lymphocytes in a syngenous system].
    Nesterenko VG, Cherniakhovskaia IIu.
    Biull Eksp Biol Med; 1977 Dec 01; 84(12):693-5. PubMed ID: 304363
    [Abstract] [Full Text] [Related]

  • 8. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M, Wettstein PJ, Korngold R.
    Transplantation; 1994 Apr 15; 57(7):1095-102. PubMed ID: 7909395
    [Abstract] [Full Text] [Related]

  • 9. [Detection of a specific differentiation antigen of mouse T-cells activated by allogenic transplantation antigens].
    Nesterenko VG, Gruner ShG.
    Biull Eksp Biol Med; 1980 Jun 15; 89(6):708-10. PubMed ID: 6967339
    [Abstract] [Full Text] [Related]

  • 10. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.
    Kinnamon KE, Blackwell LH, Ledney GD.
    Exp Hematol; 1973 Jun 15; 1(4):202-14. PubMed ID: 4154088
    [No Abstract] [Full Text] [Related]

  • 11. Cell surface receptors involved in the attachment of murine cytotoxic T lymphocytes to target cells - a study with xenoantisera to T-cell antigens.
    Rabinowitz R, Levy J, Schlesinger M.
    Thymus; 1983 Apr 15; 5(3-4):127-39. PubMed ID: 6603681
    [Abstract] [Full Text] [Related]

  • 12. Studies on natural killer (NK) cells. I. NK cell specific antibodies in CE anti-CBA serum.
    Burton RC, Winn HJ.
    J Immunol; 1981 May 15; 126(5):1985-9. PubMed ID: 7217676
    [Abstract] [Full Text] [Related]

  • 13. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA, MacDonald GC, Rector ES, Gartner JG.
    J Immunol; 1995 Nov 01; 155(9):4189-98. PubMed ID: 7594574
    [Abstract] [Full Text] [Related]

  • 14. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H, Therfelder S, Eulitz M.
    Exp Hematol; 1974 Nov 01; 2(4):195-203. PubMed ID: 4156327
    [No Abstract] [Full Text] [Related]

  • 15. [Production of heterologous antibodies to T-killers of mice immunized against H-2 antigens].
    Egorova SG, Gritsman AIu, Brondz BD.
    Biull Eksp Biol Med; 1980 Jul 01; 89(7):62-4. PubMed ID: 6157432
    [Abstract] [Full Text] [Related]

  • 16. Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease.
    Schultz KR, Paquet J, Bader S, HayGlass KT.
    Bone Marrow Transplant; 1995 Aug 01; 16(2):289-95. PubMed ID: 7581150
    [Abstract] [Full Text] [Related]

  • 17. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens.
    Korngold R, Leighton C, Mobraaten LE, Berger MA.
    Biol Blood Marrow Transplant; 1997 Jun 01; 3(2):57-64. PubMed ID: 9267665
    [Abstract] [Full Text] [Related]

  • 18. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C, George T, Devora GA, Morris MA, Gordon BE, Kumar V, Bennett M.
    Biol Blood Marrow Transplant; 1997 Dec 01; 3(6):294-303. PubMed ID: 9502296
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of mixed leukocyte culture by anti-idiotypic antibodies.
    Binz H, Askonas BA.
    Eur J Immunol; 1975 Sep 01; 5(9):618-23. PubMed ID: 11993322
    [Abstract] [Full Text] [Related]

  • 20. Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.
    Noort WA, Benner R, Savelkoul HF.
    Transplant Proc; 1995 Feb 01; 27(1):384-6. PubMed ID: 7879030
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.